Published in Bone Marrow Transplant on December 21, 2015
Venous Thrombosis in Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus (2016) 0.75
Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med (2006) 7.89
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med (2012) 6.24
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet (2013) 5.43
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med (2012) 5.25
Risk factors for venous thromboembolism. Circulation (2003) 4.64
Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial. Lancet Oncol (2013) 4.30
Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med (2006) 4.10
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer (2007) 3.27
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol (2009) 2.80
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Prophylaxis against venous thromboembolism in ambulatory patients with cancer. N Engl J Med (2014) 2.69
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet (2009) 2.59
Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med (2013) 2.52
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med (2004) 2.34
An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med (2000) 2.28
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol (2005) 2.14
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. J Thromb Haemost (2014) 2.08
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study. Blood (2014) 2.01
Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol (2011) 1.87
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide. Blood (2011) 1.76
Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation (2004) 1.73
The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med (2007) 1.70
Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol (2010) 1.64
Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost (2008) 1.49
Venous thromboembolism in the hematologic malignancies. J Clin Oncol (2009) 1.45
Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology (2001) 1.41
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. J Clin Oncol (2011) 1.32
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost (2013) 1.21
Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost (2003) 1.16
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol (2015) 1.15
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol (2005) 1.14
Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost (2008) 1.07
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res (2012) 1.05
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost (2012) 1.03
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood (2008) 1.03
Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation (2002) 1.02
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant (2003) 1.02
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost (2007) 1.02
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther (2007) 1.01
Venous thromboembolic disease. J Natl Compr Canc Netw (2013) 1.01
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood (2013) 0.98
Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost (2012) 0.98
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost (2011) 0.97
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur J Cell Biol (2001) 0.97
Deep venous thrombosis during therapy for Hodgkin's disease. Cancer Treat Rep (1985) 0.96
Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. Radiat Res (1994) 0.96
Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol (1989) 0.95
Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance. Eur J Haematol (1995) 0.91
Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant (2013) 0.91
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. Cancer Med (2014) 0.91
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev (2007) 0.89
Thrombosis in stem cell transplantation. Hematology (2012) 0.87
Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients. Bone Marrow Transplant (2005) 0.87
Endothelium and bone marrow transplantation. Bone Marrow Transplant (1996) 0.86
Incidental venous thromboembolism in oncology patients. J Thromb Haemost (2012) 0.85
Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians? Thorax (2007) 0.85
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica (2012) 0.83
The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica (2004) 0.83
Early hemostatic alterations following bone marrow transplantation: a prospective study. Haematologica (1995) 0.82
Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer. PLoS One (2014) 0.81
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. Blood Coagul Fibrinolysis (2009) 0.81
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatr Blood Cancer (2008) 0.81
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clin Lymphoma Myeloma Leuk (2015) 0.78
Central venous catheter-related thrombosis. Hematology Am Soc Hematol Educ Program (2014) 0.78
Incidence of venous thromboembolism in the setting of hematopoietic cell transplantation. Am J Ther (2014) 0.77
Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation (1991) 0.77
[Activation of endothelium-dependent hemostatic factors following bone marrow transplantation]. Schweiz Med Wochenschr (1995) 0.76
Successful use of citrate anticoagulant with heparin bolus for excessive clotting during extracorporeal photopheresis. Transfusion (2012) 0.76
Thromboprophylaxis for catheter-related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials. J Thromb Haemost (2007) 0.75
Antithrombin III in hematopoietic stem cell transplantation. Semin Thromb Hemost (1997) 0.75
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2015) 1.22
Minor RBC Ab and allo-SCT. Bone Marrow Transplant (2013) 0.87
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2014) 0.82
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT. Bone Marrow Transplant (2016) 0.76
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT. Bone Marrow Transplant (2016) 0.75
Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2016) 0.75